PhD defence R. (Romy) Schuttevaer

Advancing Acute Internal Medicine. Identifying mortality risk following infection and laboratory testing

On 6 April 2022, R. Schuttevaer will defend her PhD dissertation, entitled: ‘Advancing Acute Internal Medicine. Identifying mortality risk following infection and laboratory testing’.

Promotor
Prof.dr. A. Verbon
Promotor
Prof.dr. S.C.E. Klein Nagelvoort-Schuit
Promotor
Prof.dr. H.F. Lingsma
Co-promotor
Dr. J. Alsma
Date
Wednesday 6 Apr 2022, 13:00 - 14:30
Type
PhD defence
Space
Professor Andries Querido room
Building
Education Center
Location
Erasmus MC
Add to calendar

Dissertation in short:

Acute internal medicine is a relatively new subspecialty of internal medicine that is involved with early management of adult patients who present to the emergency department
(ED) with urgent medical conditions. Our aim was to advance the developing field of acute internal medicine by identifying mortality risk in patients with infection and by laboratory testing

In chapter 1, we provide a general introduction to the studies we performed. We explain why acute internal medicine originated as a subspecialty and how it is represented nowadays
in the ED. Also, we discuss how mortality risk is currently identified and whether there are potentials for improvement – during triage, clinical assessment (primary and secondary survey), and additional diagnostic testing. Subsequently, we describe the challenges encountered in managing patients with infection, which is a substantial part of the ED presentations for internal medicine. Also, we mention the opportunities for improving recognition of mortality risk by laboratory testing.

We conclude this chapter with stating the research questions answered in the thesis: 

  1. Can we improve recognition of mortality risk in patients presenting to the ED with infection?
    a. What is the association between body temperature and outcome?
    b. What is the predictive performance of comorbidity versus vital signs?
  2. Can we improve antibiotic therapy in the ED?
    a. What is the association between appropriate antibiotic therapy and mortality?
    b. What is the association between antibiotic guideline adherence and outcome?
  3. Can we improve identification of mortality risk by laboratory testing in the ED?
    a. What is the predictive performance of a ‘laboratory point-of-care testing’-model?
    b. What is the association between D-dimer and mortality?
More information

The public defence will begin exactly at 13.00 hrs. The doors will be closed once the public defence starts, latecomers can access the hall via the fourth floor. Due to the solemn nature of the ceremony, we recommend that you do not take children under the age of 6 to the first part of the ceremony.

 A live stream link has been provided to the candidate.

Compare @count study programme

  • @title

    • Duration: @duration
Compare study programmes